Is NBP or NGEN more undervalued in 2026?

CirclFi compares NovaBridge Biosciences (NBP) and NervGen Pharma Corp. (NGEN) using 13 institutional-grade valuation models. NBP has a Quality of Company score of 3.0/10 while NGEN scores 3.1/10.

Which is a better buy — NBP or NGEN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NBP and NGEN valuations compare?

NBP at $1.87 and NGEN at $2.08 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NBP vs NGEN Valuation Comparison 2026 — Intrinsic Value Analysis

NBP

Biotechnology

NovaBridge Biosciences

Quality

3.0

out of 10

Value Trap

SAFE

Price

$1.87

Last close

Models

9/13

Active

NGEN

Biotechnology

NervGen Pharma Corp.

Quality

3.1

out of 10

Value Trap

—

Price

$2.08

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	NBP Fair Value	NBP Upside	NGEN Fair Value	NGEN Upside
Bayesian DCF	Intrinsic	$0.37	-80.3%	$0.64	-69.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.00	-46.5%	$0.09	-95.6%
PWERM	Option-Based	$2.15	+14.9%	$2.11	+1.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NBP vs NGEN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NBP vs NGEN — Which Stock Is More Undervalued?

NGEN scores higher with a 3.1/10 quality rating vs NBP's 3.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NovaBridge Biosciences (NBP) and NervGen Pharma Corp. (NGEN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NBP currently trades at $1.87 with a QOC of 3.0/10, while NGEN trades at $2.08 with a QOC of 3.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).